Hsa_circ_0020095 modulates chemoresistance of CRC in a PDO model
BackgroundColorectal cancer (CRC) is the third most common malignant tumor type all over the world with high mortality. Chemoresistance of CRC leads to treatment failure and disease aggravation. We previously identified Hsa_circ_0020095 as a novel oncogene to promote progression and cisplatin-resist...
Saved in:
| Main Authors: | Xinyu Li, Tao Li, Yan Zhao, Junqi Shan, Yang Gao, Changchun Zhou, Yanlai Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1556611/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Hsa_circ_0023919 is a Predictive Biomarker of Chemoresistance in CRC Treatment
by: Zhang L, et al.
Published: (2024-12-01) -
Differential expression of hsa_circ_0064357 and hsa_circ_0064358 between oral squamous cell carcinoma and oral lichen planus
by: Roxana NADERI, et al.
Published: (2023-06-01) -
Diagnostic value of hsa_circ_0012138 in the chronic progression of obstructive nephropathy
by: Zhichao Huang, et al.
Published: (2025-07-01) -
Hsa_circ_0005571 promotes the proliferation and invasion of colorectal cancer cells
by: Haipeng Ge, et al.
Published: (2025-08-01) -
To explore the role of hsa_circ_0053004/hsa-miR-646/CBX2 in diabetic retinopathy based on bioinformatics analysis and experimental verification
by: Zheng Sha, et al.
Published: (2025-03-01)